LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Dasatinib | 0.37 | uM | LJP6 | 72 | hr | 513 | 525 | 10401 | 0.0505 | 0.0012 |
MCF 10A | Dovitinib | 0.37 | uM | LJP5 | 72 | hr | 513 | 3966 | 10401 | 0.3813 | 0.3492 |
MCF 10A | Enzastaurin | 0.37 | uM | LJP5 | 72 | hr | 513 | 9980 | 10401 | 0.9595 | 0.9574 |
MCF 10A | Erlotinib | 0.37 | uM | LJP5 | 72 | hr | 513 | 2357 | 10401 | 0.2266 | 0.1865 |
MCF 10A | Foretinib | 0.37 | uM | LJP5 | 72 | hr | 513 | 8179 | 10401 | 0.7864 | 0.7753 |
MCF 10A | R406 | 0.37 | uM | LJP6 | 72 | hr | 513 | 8786 | 10401 | 0.8447 | 0.8367 |
MCF 10A | Pictilisib | 0.37 | uM | LJP6 | 72 | hr | 513 | 2168 | 10401 | 0.2085 | 0.1674 |
MCF 10A | Gefitinib | 0.37 | uM | LJP6 | 72 | hr | 513 | 1020 | 10401 | 0.0981 | 0.0513 |
MCF 10A | Geldanamycin | 0.37 | uM | LJP5 | 72 | hr | 513 | 539 | 10401 | 0.0519 | 0.0026 |
MCF 10A | Geldanamycin | 0.37 | uM | LJP6 | 72 | hr | 513 | 507 | 10401 | 0.0488 | -0.0006 |
MCF 10A | GSK1059615 | 0.37 | uM | LJP5 | 72 | hr | 513 | 2539 | 10401 | 0.2442 | 0.2049 |
MCF 10A | GSK1059615 | 0.37 | uM | LJP6 | 72 | hr | 513 | 2001 | 10401 | 0.1924 | 0.1505 |
MCF 10A | GSK1904529A | 0.37 | uM | LJP6 | 72 | hr | 513 | 2532 | 10401 | 0.2434 | 0.2042 |
MCF 10A | Omipalisib | 0.37 | uM | LJP6 | 72 | hr | 513 | 536 | 10401 | 0.0515 | 0.0023 |
MCF 10A | GSK 690693 | 0.37 | uM | LJP5 | 72 | hr | 513 | 9016 | 10401 | 0.8668 | 0.8599 |
MCF 10A | GW843682X | 0.37 | uM | LJP6 | 72 | hr | 513 | 2003 | 10401 | 0.1926 | 0.1507 |
MCF 10A | HG-5-113-01 | 0.37 | uM | LJP5 | 72 | hr | 513 | 6915 | 10401 | 0.6649 | 0.6475 |
MCF 10A | HG-5-88-01 | 0.37 | uM | LJP6 | 72 | hr | 513 | 4095 | 10401 | 0.3937 | 0.3623 |
MCF 10A | Imatinib | 0.37 | uM | LJP6 | 72 | hr | 513 | 10451 | 10401 | 1.0049 | 1.0051 |
MCF 10A | JNK-9L | 0.37 | uM | LJP6 | 72 | hr | 513 | 3138 | 10401 | 0.3017 | 0.2655 |
MCF 10A | JW-7-24-1 | 0.37 | uM | LJP6 | 72 | hr | 513 | 8077 | 10401 | 0.7766 | 0.7650 |
MCF 10A | Lapatinib | 0.37 | uM | LJP6 | 72 | hr | 513 | 8542 | 10401 | 0.8213 | 0.8120 |
MCF 10A | LDN-193189 | 0.37 | uM | LJP5 | 72 | hr | 513 | 9654 | 10401 | 0.9282 | 0.9244 |
MCF 10A | Linifanib | 0.37 | uM | LJP6 | 72 | hr | 513 | 10979 | 10401 | 1.0556 | 1.0585 |
MCF 10A | Linsitinib | 0.37 | uM | LJP5 | 72 | hr | 513 | 4475 | 10401 | 0.4303 | 0.4007 |